Climb Bio GAAP EPS of -$0.13
Source: SeekingAlpha
2025-08-12 11:51:25 ET
More on Climb Bio
- Climb Bio appoints Edgar D. Charles as Chief Medical Officer
- Seeking Alpha’s Quant Rating on Climb Bio
- Historical earnings data for Climb Bio
- Financial information for Climb Bio
Read the full article on Seeking Alpha
For further details see:
Climb Bio GAAP EPS of -$0.13
Climb Bio Inc.
NASDAQ: CLYM
CLYM Trading
-3.04% G/L:
$7.01 Last:
132,812 Volume:
$7.20 Open:
CLYM Latest News
March 05, 2026 07:00:00 am
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
September 04, 2025 07:00:00 am
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
August 25, 2025 02:41:57 pm
UPDATE - Climb Bio to Present at Upcoming September 2025 Investor Conferences
CLYM Stock Data
$262,594,393
43,733,902
7.13%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Wellesley Hills
